Safety and effectiveness assessment of Pluryal gel in the treatment of androgenic hair loss
Phase 2
- Conditions
- Androgenic alopecia.Androgenic alopecia
- Registration Number
- IRCT20150101020514N15
- Lead Sponsor
- Tabesh Gostar Mehyad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Male or female aged 18-50 years
General health
Male with mild-moderate androgenic alopecia (II-IV Norwood Hamilton Scale)
Female with mild-moderate androgenic alopecia (I-II Ludwig Scale)
Voluntary participation and signing written informed consent
Exclusion Criteria
Chronic active scalp disease other than hair loss
Using any prescribed drug or OTC for hair loss within the past 3 months
Documented sensitivity to formulation components
Any severe weight loss or strict diet therapy during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hair lost Changes, based on Global photographic review. Timepoint: First injection session (visit 0), week 6 and week 24. Method of measurement: One independent dermatologist will perform clinical assessments by scoring every photograph according to the Global photographic review scale .
- Secondary Outcome Measures
Name Time Method Hair count changes. Timepoint: First injection session (visit 0), week 6 and week 24. Method of measurement: Trichoscopy By Fotofinder.